SCHEMBL30285642

SCHEMBL30285642

CCOC(=N)c1cccc(Oc2ccc3[nH]ccc3c2C(=O)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ F2 P00734 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ICAM1 P05362 1/20 0.37
▸ SELE P16581 1/20 0.37
▸ RHEB Q15382 1/20 0.37
▸ AURKA O14965 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ SNCA P37840 2/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29336928 1.00 F10 (0.40) F10MEN1MAPTKMT2AF2
SCHEMBL29338295 0.92 KDM4E (0.40) F10MAPTKDM4EHSD17B10RHEB
SCHEMBL31176868 0.90 F10 (0.41) F10MEN1MAPTKMT2AF2
SCHEMBL30285551 0.87 L3MBTL1 (0.44) MEN1MAPTKMT2AKDM4EHSD17B10
SCHEMBL29337712 0.87 L3MBTL1 (0.44) MEN1MAPTKMT2AKDM4EHSD17B10
SCHEMBL29338529 0.87 TUBB4A (0.39) F10MAPTBRD4KDM4EHSD17B10
SCHEMBL30285558 0.87 TUBB4A (0.39) F10MAPTBRD4KDM4EHSD17B10
SCHEMBL29336710 0.87 F10 (0.45) F10F2KDM4EHSD17B10
SCHEMBL29338297 0.85 KDM4E (0.38) F10MEN1MAPTKMT2AF2
SCHEMBL29337702 0.80 USP2 (0.43) F10KDM4EHSD17B10RHEBTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673137-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
WO-2024182736-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
EP-4396176-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2024-07-10 — — EP disclosed
WO-2023034946-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2023-03-09 — — WO disclosed
Send feedback